Rockwell Medical (RMTI) EPS (Diluted) Growth (1y) (2011 - 2026)
Rockwell Medical (RMTI) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | 27.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -253.43% |
| Mar 31, 2026 | -238.00% |
| Dec 31, 2025 | -283.17% |
| Sep 30, 2025 | -223.45% |
| Jun 30, 2025 | -2,573.14% |
| Mar 31, 2025 | 8.62% |
| Dec 31, 2024 | 82.68% |
| Sep 30, 2024 | 160.12% |
| Jun 30, 2024 | 101.67% |
| Mar 31, 2024 | 39.15% |
| Dec 31, 2023 | 64.01% |
| Sep 30, 2023 | 80.44% |
| Jun 30, 2023 | 67.53% |
| Mar 31, 2023 | 88.39% |
| Dec 31, 2022 | 80.52% |
| Sep 30, 2022 | 55.19% |
| Jun 30, 2022 | 42.79% |
| Mar 31, 2022 | 7.95% |
| Dec 31, 2021 | 25.05% |
| Sep 30, 2021 | 21.15% |